Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
120.00    -4.10 (-3.30%)
Bid:
119.50
Ask:
120.20
Spread: 0.70 (0.586%)
Market Cap: £1.17b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

Director/PDMR Shareholding

5 Apr 2022 11:00

RNS Number : 3076H
Oxford Nanopore Technologies plc
05 April 2022
 

5 April 2022

Oxford Nanopore Technologies plc (the "Company")

Director/PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that, on 4 April 2022, Wendy Becker, a Non-executive Director of the Company, purchased a total of 9,008 ordinary shares at a price of 388.542p per share.

Name

Number of shares acquired

Price per share (pence)

Wendy Becker

9,008

388.542p

 

This announcement is made pursuant to the Company's obligations under Article 19 of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Wendy Becker

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies PLC

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of shares in the Company

c)

Price(s) and volumes(s)

 

Price(s)

Volume(s)

388.542p

9,008

d)

Aggregated information

- Aggregated volume

 - Aggregated price

9,008 shares£34,999.86

e)

Date of the transaction

4 April 2022

f)

Place of the transaction

London Stock Exchange (XLON)

[ENDS]

For further information, please contact:

Oxford Nanopore Technologies plc

ir@nanoporetech.com

media@nanoporetech.com

Tulchan Group (communications adviser to the Company)

Tom Murray, Olivia Peters, Deborah Roney

+44 (0) 20 7353 4200

oxfordnanoporetechnologies@tulchangroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDSSGGDGDU
Date   Source Headline
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSDirector/PDMR Shareholding
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Nov 20225:00 pmRNSIssue of Equity and Total Voting Rights
11th Oct 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Oct 202212:00 pmRNSDirector/PDMR Shareholding
6th Oct 20225:30 pmRNSBlock listing Interim Review
3rd Oct 20225:00 pmRNSIssue of Equity and Total Voting Rights
29th Sep 20229:00 amRNSDirector/PDMR Shareholding
14th Sep 202211:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
12th Sep 20224:30 pmRNSOxford Nanopore to present at upcoming conferences
1st Sep 20226:30 pmRNSIssue of Equity and Total Voting Rights
24th Aug 20227:00 amRNSNotice of Results
11th Aug 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20225:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.